CURRICULUM VITAE


Born:  January 15, 1942, in Pontiac, Michigan
Married:  July 14, 1962, to Katherine Ralph, four children


Florida State University 1960-64
B.S. (Chemistry, summa cum laude) 1964

University of Minnesota 1964-68
Ph.D. (Biochemistry, minor Organic Chemistry) 1968

Michigan State University, Biochemistry Department 1968-69
Postdoctoral Research Fellow

University of Copenhagen, Division of Biological Chemistry B 1976-77
Sabbatical research in Denmark, Europe


Assistant Professor and Associate Professor 1970-87
Department of Biological Chemistry, Medical School
University of Michigan, Ann Arbor, Michigan

Assistant Dean for Research Development 1978-81
Medical School, University of Michigan

Assistant/Acting Associate Vice President for Research 1981-87
University of Michigan

National Institutes of Health, Bethesda, Maryland 1987-92

    National Institute on Aging, Genetics Program Officer 1987-88

    Office for Protection from Research Risks
        AIDS Unit Assurance Coordinator 1988-89

    Office of Scientific Integrity
        Senior Scientist and Assistant Director 1990-92

U.S. Public Health Service, Rockville, Maryland 1992-2006

    Office of Research Integrity (ORI)
        Chief, Investigations Branch 1992-99
        Acting Director, Division of Investigative Oversight 1999-2000
        Associate Director for Investigative Oversight, ORI 2000-2006 (retired)

President and CEO, Price Research Integrity Consultant Experts 2006-


Continental Baking Company Scholarship 1960-64

Basic Studies Honors Program, Florida State University 1960-62

Outstanding Baking Science Student 1961-62

Phi Eta Sigma National Freshman Honorary 1961

Phi Kappa Phi National Honorary 1964

Phi Beta Kappa National Honorary 1964

National Institutes of Health Traineeship, University of Minnesota 1964-65

National Science Foundation Graduate Fellow 1965-68

National Institutes of Health Postdoctoral Fellow, Michigan State University 1966-69

Sigma Xi National Honorary and Research Award 1969

University of Michigan Distinguished Service Award 1973

Josiah Macy Jr. Foundation Faculty Scholar Award, for sabbatical leave in Copenhagen, Denmark 1976-77

American Council on Education Fellow in Academic Administration, University of Michigan 1980-81


University of Minnesota Biochemistry Club (President in 1967) 1964-68

American Association for Advancement of Science 1965-90

American Society for Microbiology 1971-87

American Society for Biochemistry and Molecular Biology, within the
    Federation of American Societies for Experimental Biology (elected) 1975-2005

Applied Research Ethics National Association 1986-89


NIH Cash Award for special OSI projects leadership 1991
NIH Director's Award for outstanding performance 1992
PHS Cash Award for organizing ORI Plagiarism Conference 1993
PHS Outstanding DRI/ORI Team Performance Award 1996
PHS Special Cash Award for Outstanding Performance 1997
PHS Outstanding ORI Team Performance Award 1999
PHS Outstanding DIO/ORI Team Performance Award 2000
Assistant Secretary for Health Special Recognition Award 2000
PHS Outstanding DIO/ORI Team RRTA Performance Award 2002



Following my 17 years of service at the University of Michigan in Ann Arbor (1970-1987) ó as a teaching and research professor, as well as a decade as a senior research administrator in the Medical School and the University as a whole ó and following my additional 19 years of service for the Federal Government in Washington, D.C., and Rockville, Maryland (1987-2006) ó as a research grant and policy administrator at the National Institutes of Health (NIH) and as a top-level research misconduct investigator for the Office of Research Integrity (ORI) (see my detailed duties and accomplishments described below), I then chose to retire in April 2006 from full-time metro-work to the great Hill Country of Austin, Texas. There I created and registered my own professional advisory/consulting firm to continue to use my 4 decades of academic and federal expertise: Price Research Integrity Consultant Experts (P.R.I.C.E.).

Price Research Integrity Consultant Experts is a company that I created in Texas to advertise and to make available nationwide and worldwide my expert services to those institutions and individuals in need of assistance in understanding the regulations, policies, and practices that govern research misconduct investigations and standards for research integrity. I provide advice, analyze allegations and institutional policy problems, investigate specific allegations, evaluate responses to allegations and reports, write analytical reports with my professional opinions, and testify at hearings or trials if required. My clients are often legal counsels, individual complainants (whistleblowers), respondents who have been wrongly charged or wrongly convicted, and institutional officials, including Research Integrity Officers (RIOs) and counsels. I offer seminars and small group educational programs about such matters, including my major cases in ORI.

Since 2006, I have provided expert investigative and advisory services to numerous universities and research institutes on policies and investigations related to research integrity and research misconduct, including: United States Department of Justice, University of Texas at Austin, University of Pennsylvania, University of Colorado Denver, The Johns Hopkins University, Texas State University at San Marcos, St. Jude Children's Research Hospital, Stanford University, Rowan University, Rice University, Ohio University, Ohio State University, and Drexel University.

In addition, I have provided since 2006 confidential expert consulting and advisory services to individual professionals at many institutions, including: Yale University, Utah State University, University of Washington, University of Tulsa, University of Texas at Austin, University of Rhode Island, University of North Carolina at Charlottesville, University of Nebraska, University of Missouri, University of Minnesota, University of Massachusetts at Lowell, University of Louisville, University of Kentucky, University of Florida, University of Delaware, University of Connecticut Health Center, University of California at San Diego, University of California at Los Angeles, University of California at Berkeley, The Veterans Administration Medical Center in Eastern Colorado, Syracuse University, St. Lukes Hospital, Rush University, Path Medical Center, Ohio State University, Northwestern University, National Institutes of Health Intramural Program, Mt. Sinai Medical Center in New York, Michigan State University, M.D. Anderson Cancer Center, Mayo Clinic, Massachusetts Institute of Technology, Massachusetts General Hospital, Kansas University, Hampton University, George Washington University, Fred Hutchinson Cancer Research Center, Emory University, Embry-Riddle Aeronautical University, Duke University Medical Center, Danbury Hospital, Cornell University, City of Hope Medical Center, Case Western Reserve University, California State University at Los Angeles, and California Institute of Technology.

Furthermore, since 2006, I have presented several invited seminars for faculty and research staff and talked in graduate student courses at the University of Washington, University of Texas Medical Branch at Galveston, University of Texas at Austin, University of Minnesota, University of Houston, University of Arkansas for Medical Sciences, Roswell Park Cancer Institute, Massachusetts Society for Medical Research, and the Office of Research Integrity (ORI) Research Integrity Officers (RIO) Boot Camp and the 2013 ORI AT 20 Leadership Conference, as well as a webinar and four publication ethics short courses for the Council of Science Editors.

  • See P.R.I.C.E. Website:


    My administrative responsibilities and accomplishments have built upon my faculty research, administrative expertise, and interpersonal communication skills.  They have focused on leadership and service for scientists and administrative officers, in developing research areas, managing programs, and implementing institutional ethical responsibilities, both in the Federal Government and at a major research university.


    Office of Scientific Integrity/Office of Research Integrity (ORI):

    My position from 1990-1992 was Senior Scientist and then Assistant Director, Office of Scientific Integrity (OSI), Office of the Director, National Institutes of Health. In 1992, I was named Chief of Investigations Branch A, Division of Research Investigations (DRI), Office of Research Integrity (ORI), United States Public Health Service (PHS) in the Department of Heath and Human Services of the Federal Government. I served as a senior official in ORI from 1992 until 2006.

    As Assistant Director for OSI's Division C, I was responsible for managing the U.S. Public Health Service system for institutional assurance of compliance with PHS's misconduct regulations, with my review of institutional policies and procedures. Furthermore, I developed and implemented PHS policies for (1) amended assurances for small organizations unable to avoid conflicts of interests; (2) temporary restricted awards for non-assured institutions; and (3) annual reports on institutional activities and assurance updates.

    As Assistant Director for OSI and its Investigative Division A, later the ORI Investigations Branch A, my primary responsibility was the organization of cases and the structuring of OSI/ORI inquiries and investigations into alleged scientific misconduct at major research institutions. I trained and supervised several professional caseworkers in their misconduct investigation activities, as well as conducting my own investigations and writing official ORI reports for the NIH; Alcohol, Drug Abuse and Mental Health Administration (ADAMHA); and Office of the Assistant Secretary for Health.

    As Acting Director of ORIís Division of Investigative oversight (DIO) and then ORI Associate Director for Investigative Oversight, from 1999 to 2006, I reviewed, criticized, and wrote hundreds of evaluative reports on investigations conducted by universities and research centers. I oversaw and approved the similar activities by the eight senior ORI scientist-investigators with six staff members (paralegal, database manager, file clerks, writer-editor, and administrative assistant).

    Additionally, I worked on research misconduct cases conjointly with the Office of Inspector General of the National Science Foundation (NSF). Many of our 750 cases involved major evidence of scientific misconduct (plagiarism, falsification, or fabrication of research results). Interactions with university and PHS institute and agency officials (including answering their questions, arranging visits, asking them to sequester original notebooks for investigation, and evaluating their reports) were a sensitive and important aspect of my responsibilities for ORI. In other areas, I organized and made presentations at ORIís national workshops: to educate research integrity officers and other university officials on ORIís investigative and assurance procedures; to foster interactions with editors of biomedical journals; and to encourage national interchanges on issues involving plagiarism or "curbstoning" by survey interviewers. I have also given formal talks at many university symposia and at national conferences, as well as international meetings across the Western Hemisphere.

    Office for Protection from Research Risks (OPRR) at the National Institutes of Health (NIH):

    In 1988-1999, I was the Assurance Coordinator and the chief administrator for the new AIDS Unit in NIH's Office for Protection from Research Risks (OPRR). I was responsible for negotiating institutional Single Project Assurances with extramural institutions, for protection of human subjects in AIDS research supported by NIH, ADAMHA, Centers for Disease Control (CDC), etc.

    I had daily communications with university officials and Institutional Review Board chairpersons about their meeting the requirements of the PHS regulations, particularly in regard to the informed consent document proposed for their PHS application research, and in regard to the new PHS policy for informing those tested of their HIV-serostatus.

    I also organized an expert panel for the OPRR Director to advise the Secretary of the Department of Health and Human Services on the ethics of a sensitive proposal for AIDS research using prisoners.

    National Institute on Aging (NIA) at the National Institutes of Health (NIH):

    In my first year at NIH, 1987-88, I was the Program Officer responsible for all genetics applications and grants in the National Institute on Aging (NIA), in the Biomedical Research and Clinical Medicine Division, Molecular and Cell Biology Branch.

    My NIA portfolio included about 100 grants on genome cloning and gene expression directed toward an understanding of the basic nature of aging.  In addition to working with the scientists in the field and the NIH study sections and NIA Advisory Council, I wrote a Program Announcement on Sex Chromosomes and Aging, in follow-up to our Conference on Gender and Longevity.

    I coauthored a review article on Mutation, Cancer and Aging. In addition, I developed a DBASE III+ data base for tracking the Branch's applications and grants, including the ability to search for key words and generate reports for the NIA Director and Congress on specific areas (such as the use of recombinant DNA technology in biomedical research on aging).


    My positions in research administration at the University of Michigan, Ann Arbor, during the prior decade (1977-1987), were within the Medical School Dean's Office as Assistant Dean for Research Development, and in the central administration's Office of the Vice President for Research as Assistant/Associate Vice President for Research, including the primary delegated responsibility for management of the review and award process for pilot research or equipment grants.

    These positions involved the delegated responsibility for the assurances and oversight monitoring for sensitive biosafety concerns at the University: human and animal subjects (with the NIH OPRR), recombinant DNA, chemical and biological hazard liaison, radioisotopes, etc.  It further involved coordination for the University on other sensitive, public issues (see below). Some of my major administrative responsibilities and accomplishments at the University of Michigan were:

    Management of Research Funding Requests (1978-81 and 1982-87):

    I coordinated for the Dean and the Vice President the review and decision-making process for the NIH Biomedical Research Support Grants, and the Preliminary Research, Research Maintenance, and Research Equipment accounts (about $1 million in total annually).

    Conflicts of Interest and Commitment Task Force Report (1984-85):

    I created for three Vice Presidents, and chaired, the University Task Force to develop the new Policy Statement on Avoidance of Conflicts of Interest and Commitment for the University faculty and staff.

    Unit for Laboratory Animal Medicine Review and Search (1984-85):

    I wrote the charge for, and served, on the review and search committee for the Dean and the Vice President, to select the new Director of Laboratory Animal Medicine.

    Radiation Control Service Review and Search (1985-86):

    I wrote the charge, recruited the members, and served myself on the review and search committee for the Vice President, to select the new Director of Radiation Control Service.

    Radiowaste Management Plans (1985-87):

    I represented the Vice President for Research's Office and authored the report of the committee which recommended a facility on campus to process and store University radioactive research wastes.  I also represented the University as liaison to the State Governor's Radioactive Waste Control Committee, educating the public and seeking a State disposal site.

    Research Excellence Fund Proposal on Protein Design (1985-86):

    I authored the University proposal to the State's Research Excellence and Economic Development Fund, focusing on our faculty's strengths in Protein Engineering and Design (it was later funded at $0.9 million).

    Center for Molecular Genetics (1980-87):

    I worked with a group of fifty cross-campus faculty with expertise in molecular genetics, to organize a retreat, write a proposal for the University's Thurnau Trust competition, and create a Vice Presidential Center for Molecular Genetics, to foster this area of biotechnology in the University and the State, and to help recruit faculty and postdoctoral and graduate students to the University.

    Michigan Technology Council Biomedical Committee (1981-87): 

    I chaired for two years the university/industry liaison group of scientists and administrators, focused on biotechnology and its commercialization in Ann Arbor and the State.

    Animal Research Issues Group (1985-87):

    I created and chaired, for four Vice Presidents, a cooperative staff group to coordinate the University's internal and external positions on issues related to the use of animals research.  Its members represented Public Relations, State and Community Relations, Lab Animal Medicine, Security, and faculty of own Statewide Michigan Society for Medical Research (to whose Board I was elected).

    I organized a meeting with the local and State humane societies, and I wrote responses to concerned citizens about the University's research with animals.  I coordinated the recruitment and selection of the outside members of the University's Committee on Use and Care of Animals, serving ex officio.

    Furthermore, I helped to write the University's Animal Assurance for submission to NIH OPRR.  I participated in several OPRR, PRIM&R, and NABR national conferences on animal use (and for one OPRR Midwest conference, I hosted the group at the University of Michigan).  I gave a talk on our system at an ARENA meeting, published in ARENAís newsletter and "Grants Magazine".

    Committee of Human Subjects Review Committees' Chairpersons (1981-87):

    I chaired for the Vice President the University's central "appeals and policy committee" for protection of human subjects in research, consisting of the chairpersons of the twelve school/college Institutional Review Boards.  I wrote the University Assurance for Human Subjects protection for submission to OPRR.

    Integrity of Scholarship and Fraud Investigation (1984-86):

    I recommended to the Vice Presidents, created, and served on a Task Force on Integrity in Research, coordinating its report and review/approval process through the various University channels.  I also privately advised faculty and students about misconduct (plagiarism) directed against them.

    Teaching Students and Supporting University Education Programs:

    As Associate Professor of Biological Chemistry at the University of Michigan Medical School, I taught each year courses to students in medicine, nursing, dentistry, undergraduate college and graduate school.  In 1973, I won one of six University Distinguished Service Awards for my teaching efforts.

    I was co-creator in 1983-86 of a new Biochemistry course for the innovative Inteflex Program, an integrated B.S./M.D. six-year degree program.

    As Assistant Dean in the Medical School in 1980-81, I was co-originator of an NIH-funded Medical Scientists Training Program, to support fifteen joint M.D./Ph.D. students at Michigan.

    Professional Work Outside the University:

    Reviewer of Grant proposals in Biochemistry and
        Molecular Biology, for U.S. Department of Energy 1974-75
        and for the National Science Foundation 1978-80,1987

    Reviewer of Manuscripts for Professional Journals: 1972-82
        Journal of Virology 1972-81
        Biochemical & Biophysical Research Communications 1976
        Journal of Biological Chemistry 1971,1978
        Proceedings, National Academy of Sciences 1981-82
        Biochemistry 1975-78
        Canadian Journal of Biochemistry 1974

    Reviewer of Biochemistry Textbook Manuscripts for Publishers: 1971-87
        John Wiley & Sons Inc. Benjamin Inc.
        Houghton Mifflin Inc. Addison-Wesley Inc.
        Saunders Company Random House Inc.
        MacMillan Company Scientific American Books

    Ethics and Values Group Member (The William Bottum
        Community Group): Sponsoring Group Member 1986-87

    Michigan Society for Medical Research
        Elected Member, State Board of Directors 1986-87


    Licensed foster parent, for 13 children (periods of one to six months)
        for the Countyís Department of Social Services and for
        Child and Family Services, Ann Arbor, Michigan 1975-80

    Parish Education Committee (Chair) and Seminar Committee
        Trinity Evangelical Lutheran Church, Ann Arbor, Michigan 1980-1982

    National Marriage Encounter of Ann Arbor:
        Team member, presenting 10 Couple Weekends: 1978-87
        Ann Arbor President, and Detroit Board Member: 1983-87

    Geneva Presbyterian Church, Rockville, Maryland 1987-2006
        Clerk of Session, Bell Choir, Sanctuary Choir, Players, Speaking Chorus, Lector


    Enzymology of Deoxyribonucleic Acid Biosynthesis; Role of Unusual Nucleosides
    in Nucleic Acids; Biochemistry of Virus Infections of Bacillus subtilis


    U.S. Atomic Energy Commission / Energy Research and Development Administration / Department of Energy Research Grant, "Synthesis of DNA Containing Uracil or 5-Hydroxymethyluracil during Bacteriophage Infection of Bacillus subtilis", 1970-83, $360,000.


    Publications in Scholarly Journals:

    Undergraduate Research:

    1. Bayfield, E.G., Young, W.E., and Price, A.R.,  Flour Brew Studies. VIII. Water as an Ingredient: Effect of Calcium and Magnesium Ions.  Bakers Digest 39, No. 2, 58-64 (1965)

    2. Bayfield, E.G., Young, W.E., and Price, A.R.,  Flour Brew Studies. IX. Some Effects of Mono-calcium Phosphate and Calcium Gluconate in Brew Water.  Bakers Digest 39, No. 3, 47-49 (1965)

    Graduate Research:

    3. Price, A.R., and Warner, H.R.,  A Structural Gene for Bacteriophage T4- Induced Deoxycytidine Triphosphate - Deoxyuridine Triphosphate Nucleotidohydrolase.  Virology 36, 523-526 (1968)

    4. Price, A.R., and Warner, H.R.,  Bacteriophage T4-Induced Deoxycytidine Triphosphate - Deoxyuridine Triphosphate Nucleotidohydrolase: Its Properties and its Role during Phage Infection of Escherichia coliVirology 39, 882-892 (1969)

    Postdoctoral Research:

    5. Price, A. R., and Rottman, F.,  Nucleic Acids from Saprospira grandis: The Absence of 2'-0-methyl-RNA.  Biochimica et Biophysica Acta 199, 288-291 (1970)

    6. Price, A. R., and Rottman, F.,  2'-0-Methyloligoadenylates as Templates for the Binding of Lysyl Transfer Ribonucleic Acid to Ribosomes.  Biochemistry 7, 4524-4529 (1970)

    Faculty Research:

    7. Price, A. R., and Cook, S. J.,  New Deoxyribonucleic Acid Polymerase Induced by Bacillus subtilis Bacteriophage PBS2.  Journal of Virology 9, 602-610 (1972)

    8. Price, A. R., and Frabotta, M.,  Resistance of Bacteriophage PBS2 Infection to Rifampicin, an Inhibitor of Bacillus subtilis RNA Synthesis.  Biochemical & Biophysical Research Communications 48, 1578-1585 (1972)

    9. Price, A. R., Dunham, L. F., and Walker, R. L.,  Thymidine Triphosphate Nucleotidohydrolase and Deoxyuridylate Hydroxymethylase Induced by Mutants of Bacillus subtilis Bacteriophage SP82G.   Journal of Virology 10, 1240-1241 (1972)

    10. Price, A. R., and Fogt, S. M.,  Deoxythymidylate Phosphohydrolase Induced by Bacteriophage PBS2 During Infection of Bacillus subtilisJournal of Biological Chemistry 248, 1372-1380 (1973)

    11. Price, A. R., and Fogt, S. M.,  Resistance of Bacteriophage PBS2 Infection to 6-(p-hydroxy-phenylazo)-uracil, an Inhibitor of Bacillus subtilis Deoxyribonucleic Acid Synthesis.  Journal of Virology 11, 338-340 (1973)

    12. Price, A.R., and Fogt, S.M.,  Effect of Nalidixic Acid on PBS2 Bacteriophage Infection of Bacillus subtilisJournal of Virology 12, 405-407 (1973)

    13. Dunham, L. F., and Price, A. R.,  Deoxythymidine Triphosphate-Deoxyuridine Triphosphate Nucleotidohydrolase Induced by Bacillus subtilis Bacteriophage phi e.  Biochemistry 13, 2667-2672 (1974)

    14. Dunham, L. T., and Price, A. R.,  Mutants of Bacillus subtilis Bacteriophage phi e defective in dTTP-dUTP Nucleotidohydrolase.  Journal of Virology 14, 709-712 (1974)

    15. Price, A. R.,  Bacteriophage PBS2 Induced Deoxycytidine Triphosphate Deaminase in Bacillus subtilisJournal of Virology 14, 1314-1317 (1974).

    16. Price, A. R., Hitzeman, R., Frato, J., and Lombardi, K.,  Rifampicin-Resistant Bacteriophage PBS2 Infection and RNA Polymerase in Bacillus subtilisNucleic Acids Research 1, 1497-1502 (1974)

    17. Post, L., and Price, A. R.,  Inhibition of Bacteriophage PBS2 Replication in Bacillus subtilis by Phleomycin.  Journal of Virology 15, 363-371 (1975)

    18. Price, A. R., and Frato, J.,  Bacillus subtilis Deoxyuridine Triphosphatase and its Bacteriophage PBS2-Induced Inhibitor.  Journal of  Biological Chemistry 250, 8804-8811 (1975)

    19. Katz, G. E., Price, A. R., and Pomerantz, M. J.,  Bacteriophage PBS2-Induced Inhibition of Uracil-Containing DNA Degradation.  Journal of Virology 20, 535-538 (1976)

    20. Neuhard, J., Price, A. R., Schack, L., and Thomassen, L.,  Two Thymidylate Synthetases in Bacillus subtilisProceedings of the National Academy of Sciences U.S.A. 75, 1194-1198 (1978)

    21. Hitzeman, R. A., Hanel, A. N., and Price, A. R.,  Dextran Sulfate as a Contaminant of DNA Extracted from Concentrated Viruses and as an Inhibitor of DNA Polymerase.  Journal of Virology 27, 255-257 (1978)

    22. Hitzeman, R. A., and Price, A. R.,  Relationship of Bacillus subtilis DNA Polymerase III to Bacteriophage PBS2-Induced DNA Polymerase and to the Replication of Uracil-containing DNA.  Journal of Virology 28, 697-709 (1978)

    23. Hitzeman, R. A., and Price, A. R.,  Bacillus subtilis Bacteriophage PBS2-Induced DNA Polymerase: Its Purification and Assay Characteristics.  Journal of Biological Chemistry 253, 8518-8525 (1978)

    24. Hitzeman, R. A., and Price, A. R.,  Characterization of the Bacillus subtilis Bacteriophage PBS2-Induced DNA Polymerase and Its Associated Exonuclease Activity.  Journal of Biological Chemistry 253, 8526-8533 (1978)

    25. Price, A. R., and Neuhard, J.,  Deoxyribonucleotide Metabolism in PBS2 Phage-Infected Bacillus subtilis: The Discovery of Deoxyuridine Triphosphate in vivo. (unpublished manuscript)

    26. Price, A. R.,  A Mutant of Bacteriophage PBS2 Defective in an Inhibitor of Bacillus subtilis Uracil-DNA N-glycosylase. (unpublished manuscript)

    Chapters in Books:

    Faculty Research Work:

    1. Price, A. R., A Bacteriophage-Induced Inhibitor of a Host Enzyme (Presented at the American Society for Microbiology's Bacilli Conference, Cornell University), in Microbiology (Schlessinger, D.,ed.) p. 290-294 (1976)

    2. Price, A. R., Thymidylate Phosphohydrolase from PBS2 Phage-Infected Bacillus subtilisMethods in Enzymology 51, 285-290 (1978)

    3. Hitzeman, R. A., Price, A. R., Neuhard, J., and Mollgaard, H. Deoxyribonucleotide Triphosphate and DNA Polymerase in Bacteriophage PBS1-Infected Bacillus subtilis. (Presented at the NATO Advanced Study Institute on DNA Synthesis in Sicily), in DNA Synthesis: Present and Future (I. Molineaux and M. Kohiyama, eds.), Plenum Press, New York, p. 255-266 (1978)

    Federal Work:

    4. Warner, H. R., and Price, A. R.,  Mutations, Cancer and Aging. A Review, in a special issue of the Journal of Gerontology 244, 45-54 (1989)

    Miscellaneous Publications:

    Faculty Research and Teaching:

    1. Hultquist, D. E., Marino, J. P., Martin, M. M., and Price, A. R.,  A Four-Semester Chemistry-Biochemistry Sequence for Students in Medical Training, Journal of Medical Education 51, 57-59 (1976)

    2. Price, A. R.,  Teaching Organic and Biological Chemistry to Nursing Students, Biochemical Education 4, 11-12 (1976)

    3. Price, A. R.,  a book review of Handbook of Biochemistry and Molecular Biology: Nucleic Acids, Volume 1, 3rd Edition (Fasman, G.D., ed.) in Journal of the American Chemical Society 98, 6422 (1977)


    Research-Administrative Papers:

    For the University of Michigan:

    1. Price, A. R.,  Dealing with Scientists who Cheat, a book review of Betrayers of the Truth by William Board and Nicholas Wade, in Chemical and Engineering News (June 13), pg. 68-70 (1983)

    2. Price, A. R.,  Streamlining the Animal Research Review Process While Informing All Members of the Committee, Grants Magazine 10, 99-102 (1987)


    For NIH/OPRR:

    3. Price, A. R.,  Assurance of Protection of Human Subjects from Research Risks: AIDS Research, ARENA Newsletter, Vol. 1, No. 10, p.3 (December 1988)

    4. Price, A. R.,  Risks to Human Subjects in AIDS Research: Compliance with Regulations and Policies, ARENA Newsletter, Vol. 2, No. 4, p. 4 (December 1989)


    For NIH/OSI and PHS/ORI:

    5. Price, A.R ., and Hallum, J. V.,  The Office of Scientific Integrity Investigations: the Importance of Data Analysis, Accountability in Research 2, 133-137 (1992)

    6. Price, A. R.,  The Role of the Office of Research Integrity and the Professional Societies in Fostering Integrity in Biomedical and Behavioral Science, Journal of Exposure Analysis and Environmental Epidemiology 3, Suppl. 1, 9-20 (1993)

    7. Price, A. R.,  Organizer and Chairman for the Office of Research Integrity/American Association for the Advancement of Science "Conference on Plagiarism and Theft of Ideas," National Institutes of Health, Bethesda, Maryland (June 21-22, 1993) [full Conference Proceedings were printed for distribution by ORI in 1995] [ the proceedings were also published on ORIís Web Site online at (1993) -- three session reports at online1, online2, and online3].

    8. Fields, K. L., and Price, A. R.,  Problems in Research Integrity Arising from Misconceptions About Ownership of Research, Academic Medicine (Supplement) 68(9), S60-S64 (1993) online

    9. Price, A. R.,  Definitions and Boundaries of Research Misconduct: Perspectives from a Federal Government Viewpoint, Journal of Higher Education 65(3), 286-297 (May/June 1994)

    10. Price, A. R.,  The 1993 ORI / AAAS Conference on Plagiarism and Theft of Ideas, Journal of Information Ethics 3(2): 54-63 (Fall 1994)

    11. Price, A. R.,  Federal Actions Against Plagiarism in Research, Journal of Information Ethics 5: 34-51 (Spring 1996)

    12. Price, A. R.,  Anonymity and Pseudonymity in Whistleblowing to ORI about Misconduct in Biomedical Research, Academic Medicine 73:467-472 (1998), online

    13. Price, A. R.,  Federal Actions Against Plagiarism in Research, a reprinting of the 1996 Journal of Information Ethics article, on request for: The Encyclopedia of Library and Information Science (A. Kent, editor) Volume 62, Suppl. 25, pp. 132-146 (August 1998)

    14. Price, A. R.,  Institutional and Government Interactions, Conference on Ethical Challenges and Practical Solutions for Managers in Research, Albuquerque, New Mexico, published by Sigma Xi in the Proceedings, pp. 53-83 (February 2000

    15. Price, A.R., Coming Full Circle: Can Misconduct Be Prevented? - a panel presentation (pp. 6-8) at the Council of Science Editorsí Retreat, Landsdowne, Virginia (November 9, 2003)

    16. Price, A. R.,  Curbstoning in survey research and required reporting to the Office of Research Integrity, 2004 Proceedings of the American Statistical Association, Statistical Methods Section [CD-ROM].

    17. Price, A. R.,  a book review of The Great Betrayal: Fraud in Science
    by Horace F. Judson, Harcourt Press, New York, 2004, Journal of Clinical Investigation 115: 198 (2005)

    18. Price, A. R.,  Cases of plagiarism handled by the United States Office of Research Integrity, Plagiary 1:1-11 (2006) online

    19. Abbrecht, P., Davidian, N., Merrill, S., and Price, A.R., The Role of the Office of Research Integrity in Cancer Clinical Trials, Chapter 13, pp. 231-239, in: Cancer Clinical Trials: Proactive Strategies, edited by Stanley P.L. Leong, Springer, New York (2007)

    20.  Soskolne, C.L., Abbrecht, P.H., Davidian, N.M., and Price, A.R., "Good conduct and integrity in epidemiologic research," Chapter 13, pp. 264-282, in:  Ethics and Epidemiology, 2nd Edition, edited by Steven Coughlin, Tom Beauchamp, and Douglas Weed, Oxford University Press (2009)


    Research-Administrative Papers and Presentations for P.R.I.C.E. as Private Consultant on Research Misconduct:

    1. Price, A.R., Major Cases of the Office of Research Integrity, and How to Protect Yourself from Research Misconduct in Your Laboratory, talks for the research ethics training courses and seminar for Cell and Molecular Biology Program graduate students at the University of Texas at Austin, in Austin, Texas (January 10, February 25, and May 29, 2008)

    2. Price, A.R., Major Cases of the Office of Research Integrity, and How to Protect Yourself from Research Misconduct in Your Laboratory, talk for the research ethics training course for Psychology and Neuroscience graduate students at the University of Texas at Austin, in Austin, Texas (February 19, 2008)

    3. Price, A.R., Major Cases of the Office of Research Integrity, and How to Protect Yourself from Research Misconduct in Your Laboratory, talk for the research ethics training course for graduate students at the University of Texas Medical Branch, Galveston, Texas (May 21, 2008)

    4.  Price, A.R., ORI Clinical Fraud Cases including Plagiarism" and "Research Misconduct cases and the ORI, talks for faculty, students and staff of the Arkansas Children's Hospital Research Institute at The University of Arkansas for Medical Sciences, in Little Rock, Arkansas (December 15, 2009)

    5.  Price, A.R., Career Choices and Research Integrity in Biochemistry, talk for the Biochemistry Graduate Student Seminar, University of Texas at Austin, Austin, Texas (February 8, 2011)

    6. Price, A.R., The Office of Research Integrity and Misconduct Cases - Interactions with Journal Editors, a webinar presentation for the Council of Science Editorsí Ethics Education Committee, online from Pontiac, Michigan, broadcasting countrywide on a panel of experts (August 23, 2011)

    7. Price, A.R., ORI cases and How to Protect Yourself from Research Misconduct in Your Laboratory," the first talk for their NSF Distinguished Speaker Seminar Series on Experiencing Ethics, University of Houston, Houston, Texas (November 7, 2011)

    8. Price, A.R., Scenarios for Graduate Students in Research Ethics, talk for the Computational Physiology Graduate Students, University of Houston, Houston, Texas (November 7, 2011)

    9. Price, A.R., ORI cases and How to Protect Yourself from Research Misconduct in Your Laboratory, talk for the faculty of at the Stem Cell Research Division of the University of Washington Medical School, South Lake Union, Seattle, Washington (May 18, 2012)

    10. Price, A.R., and Daroff, R. (former Editor-in-Chief of Neurology), Model for Editor and ORI Cooperation in Handling the Allegation, Investigation, and Resolution of a Difficult Case of Research Misconduct (against Dr. James Abbs, University of Wisconsin), talk for the Council of Science Editors Annual Meetingís Short Course on Publication Ethics, Seattle, Washington (May 19, 2012)

    11. Price, A.R., The Federal Response to Research Misconduct, 1980-present, and the Construction of 42 CFR 50 Part A and Subsequently 42 CFR Part 93, keynote speech for the ORI AT 20: Reassessing Research Integrity: A Leadership Conference, Baltimore, Maryland (April 3, 2013)

    12. Price, A.R., Public Research Misconduct Case in Texas: what we can learn from them, an invited talk for faculty and students of the University of Houston, Houston, Texas (April 29, 2013)

    13. Price, A.R., Research Misconduct and its Federal Regulation: the origin and history of the Office of Research Integrity -- with personal views by ORI's former Associate Director for Investigative Oversight, Accountability in Research 20(5-6):291-319 (2013)  online

    14. Price, A.R., Public research misconduct cases in Texas: what we can learn from them, an invited talk for biochemistry graduate students of the University of Texas, Austin, Austin, Texas (October 14, 2013)

    15. Price, A.R., and Daroff, R., Historical model for editor and Office of Research Integrity cooperation in handling allegations, investigation, and retraction in a contentious (Abbs) case of research misconduct, Accountability in Research 22(2):63-80 (2015) online

    16. Price, A.R., Editor, RIO, and ORI Cooperation in Handling Allegations, Investigations, and Resolution of Cases of Research Misconduct, talk for Council of Science Editors Annual Meetingís Short Course on Publication Ethics, Denver, Colorado (May 15, 2016)

    17. Price, A.R., Editor, RIO, and ORI Cooperation, and Issues of Fairness, in Handling Allegations, Investigation, and Resolution of Difficult Cases of Research Misconduct and Retraction, talk for Council of Science Editors Annual Meetingís Short Course on Publication Ethics, New Orleans, Louisiana (May 6, 2018)

                                            Contact Dr. Price at:

                                            See Price Research Integrity Consultant Experts

    Hit Counter